HKPD Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.…
Industry Peers
Medical DistributionKey Statistics
About Cellyan Biotechnology (NASDAQ: HKPD)
›
Cellyan Biotechnology (NASDAQ: HKPD) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 11 employees.
The shares were at 1.345 USD on 19 November 2026, down 94.4% over 52 weeks. Its 52-week range is 1.200 USD to 29.00 USD: the price is 95.4% below the high and 12.1% above the low.
Its market capitalisation is 3.32M USD.
Cellyan Biotechnology reports return on equity of -11.9%, an operating margin of -7.5% and revenue down 31.7% year over year.
Its debt exceeds its cash by 1.04M USD, a debt-to-equity ratio of 0.13. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.